# Antidepressant Therapy for Bipolar II Major Depression

> **NCT00641927** · PHASE4 · COMPLETED · sponsor: **Stanley Medical Research Institute** · enrollment: 90 (actual)

## Conditions studied

- Bipolar Type II Disorder

## Interventions

- **DRUG:** Venlafaxine
- **DRUG:** Lithium Carbonate

## Key facts

- **NCT ID:** NCT00641927
- **Lead sponsor:** Stanley Medical Research Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2002-04
- **Primary completion:** 2006-10
- **Final completion:** 2006-10
- **Target enrollment:** 90 (ACTUAL)
- **Last updated:** 2008-03-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00641927

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00641927, "Antidepressant Therapy for Bipolar II Major Depression". Retrieved via AI Analytics 2026-07-09 from https://api.ai-analytics.org/clinical/NCT00641927. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*